{"nct_id":"NCT05382325","title":"A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2022-06-16","start_date_type":"ACTUAL","primary_completion_date":"2026-07-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-07-31","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["MRK"]}